| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000010850 |
| Receipt No. | R000012693 |
| Official scientific title of the study | Japan registry to use of Promus element in acute coronary syndrome patients |
| Date of disclosure of the study information | 2013/06/01 |
| Last modified on | 2016/12/08 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Japan registry to use of Promus element in acute coronary syndrome patients | |
| Title of the study (Brief title) | J-POSEIDON registry | |
| Region |
|
|
| Condition | ||
| Condition | Acute Coronary Syndrome | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the safety and clinical outcomes with a platinum chromium everolimus-eluting
stent(PROMUS) in acute coronary syndrome patients |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Major adverse cardiac event including cardiac death, myocardial infarction, and target lesion revascularization at 12
mont |
| Key secondary outcomes | TLR at 9 month/24 month
TVR at 9 month/24month MI at 9 month/24 month Death at 9 month/24 month MACE at 9 month/24 month Stent thrombosis (acute, sub-acute, late, and very late) defined by Academic Research Consortium (ARC) at 9 month/ 24 month |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Define ACS (Acute coronary syndrome) as UA (unstable angina), NSTEMI (Non-ST Elevation Myocardial Infarction) and STEMI (ST Elevation Myocardial Infarction).
AMI have an onset within 24 hours and meet the criteria "Universal Definition of Myocardial Infarction" defined by ESC/ACCF/AHA/WHF task force. A)Having a diagnosis of any ACS symptom B)De-novo lesion in a target vessel C)Indication for PCI D)PROMUS stent should be used with on-label use or physician assesses PROMUS stent is an appropriate device for the patient. E)Should be deployed PROMUS stent. |
|||
| Key exclusion criteria | F)Enrolled in another study (excluding PMS) or receiving any treatment affected the registry.
G)Pregnant or possibility of pregnancy in the registry period. H)Known hypersensitivity reaction to everolimus, polymer, metal I)Known hypersensitivity reaction to antiplatelet J)Improper functioning of the liver K)Kidney malfunction(>=3.0mg/dl serum creatinine level) or dialysis treatment. L)Active cancer M)Lesion in saphenous vein graft N)cardiogenic shock by clinical assessment |
|||
| Target sample size | 500 | |||
| Research contact person | |
| Name of lead principal investigator | Satoru Otsuji, Junya Shitte, Yoshinori Yasaka |
| Organization | Higashi Takarazuka Satoh Hospital, Osaka Saiseikai Nakatsu Hospital , Hyogo Brain and Heart Center |
| Division name | Cardiology |
| Address | Saisyoko 520, Himeji, Hyogo, Japan 6700981 |
| TEL | 079-293-3131 |
| j.poseidon.registry@gmail.com | |
| Public contact | |
| Name of contact person | Yoshinori Yasaka |
| Organization | Hyogo Brain and Heart Center |
| Division name | Cardiology |
| Address | Saisyoko 520, Himeji, Hyogo, Japan 6700981 |
| TEL | 079-293-3131 |
| Homepage URL | |
| j.poseidon.registry@gmail.com | |
| Sponsor | |
| Institute | Society of ACS Intervention and
Therapeutics |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Society of ACS Intervention and
Therapeutics |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東宝塚さとう病院(兵庫県)
大阪府済生会中津病院(大阪府) 兵庫県立姫路循環器病センター(兵庫県) その他募集中 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | prospective, multi-center |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000012693 |